ArticleInternational journal of molecular sciences2024

A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model.

Aleksandra Bober et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.